Moreover, oleocanthal suppressed the receptor for advanced glycation end products/high mobility group box 1 (RAGE/HMGB1) pathway [80], which is also involved in the activation of the NF-κB pathway and related neuroinflammation in Alzheimer’s disease [81]. Here, NFKB1 is linked to early-onset autosomal dominant Alzheimer disease.